Infinimmune
PrivateLast Round
Series A
Aug 11, 2026
Total Funding Raised
$87M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Infinimmune is a biotechnology company that develops human-derived antibody medicines by discovering antigen-specific antibodies from human B cells via proprietary sequencing and AI-guided engineering platforms.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Infinimmune Comparables
Compare Infinimmune with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BigHat Biosciences | 87% | |
| AbTherx, Inc. | 84% | |
| BioLoomics | 84% | |
Infinimmune Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Aug 11, 2026 | ||||
| Seed | Dec 6, 2022 |
Key People
Founding team and executive leadership
Infinimmune Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| Playground Global | Seed |
| Wild Tree Ventures | Series A |
| Pear VC | Seed, Series A |
| Forge Life Science Partners | Series A |
| Everbright Biofund | Series A |
| Goldcrest Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 11, 2026
$75M round led by Playground Global and Regeneron Ventures.
- Apr 27, 2026
Anthony Slavin appointed as new SVP of Portfolio Strategy.
Infinimmune Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Infinimmune's valuation, stock price, and market status.